DK0981537T3 - Smitsom klon af humant parainfluenzavirus type 3 - Google Patents

Smitsom klon af humant parainfluenzavirus type 3

Info

Publication number
DK0981537T3
DK0981537T3 DK98922118T DK98922118T DK0981537T3 DK 0981537 T3 DK0981537 T3 DK 0981537T3 DK 98922118 T DK98922118 T DK 98922118T DK 98922118 T DK98922118 T DK 98922118T DK 0981537 T3 DK0981537 T3 DK 0981537T3
Authority
DK
Denmark
Prior art keywords
hpiv
clone
protein
nucleotide sequence
genome
Prior art date
Application number
DK98922118T
Other languages
Danish (da)
English (en)
Inventor
Amiya K Banerjee
Michael A Hoffman
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Application granted granted Critical
Publication of DK0981537T3 publication Critical patent/DK0981537T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18621Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18651Methods of production or purification of viral material
    • C12N2760/18652Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK98922118T 1997-05-07 1998-05-06 Smitsom klon af humant parainfluenzavirus type 3 DK0981537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4580597P 1997-05-07 1997-05-07
PCT/US1998/009270 WO1998050405A1 (en) 1997-05-07 1998-05-06 An infectious clone for human parainfluenza virus type 3

Publications (1)

Publication Number Publication Date
DK0981537T3 true DK0981537T3 (da) 2007-11-19

Family

ID=21939986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98922118T DK0981537T3 (da) 1997-05-07 1998-05-06 Smitsom klon af humant parainfluenzavirus type 3

Country Status (16)

Country Link
US (1) US6248578B1 (de)
EP (1) EP0981537B1 (de)
JP (1) JP2002512519A (de)
KR (2) KR100585946B1 (de)
CN (1) CN1208340C (de)
AT (1) ATE367397T1 (de)
AU (1) AU736586B2 (de)
BR (1) BR9809240A (de)
CA (1) CA2289776C (de)
CY (1) CY1107730T1 (de)
DE (1) DE69838097T2 (de)
DK (1) DK0981537T3 (de)
ES (1) ES2289782T3 (de)
HK (1) HK1025973A1 (de)
PT (1) PT981537E (de)
WO (1) WO1998050405A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465574B2 (en) 1994-09-30 2008-12-16 Medimmune, Llc Recombinant RSV virus expression systems and vaccines
US6830748B1 (en) 1997-09-26 2004-12-14 Medimmune Vaccines, Inc. Recombinant RSV virus expression systems and vaccines
US6764685B1 (en) * 2000-03-21 2004-07-20 Medimmune Vaccines, Inc. Recombinant parainfluenza virus expression systems and vaccines
CA2477234C (en) * 2002-02-21 2014-12-30 Medimmune Vaccines, Inc. Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
US20100316991A1 (en) * 2009-06-11 2010-12-16 Utah State University Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
PT702085E (pt) * 1994-07-18 2004-04-30 Karl Klaus Conzelmann Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
US5869036A (en) * 1995-12-08 1999-02-09 St. Louis University Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine

Also Published As

Publication number Publication date
WO1998050405A1 (en) 1998-11-12
KR100678818B1 (ko) 2007-02-07
CN1208340C (zh) 2005-06-29
AU736586B2 (en) 2001-08-02
CA2289776A1 (en) 1998-11-12
BR9809240A (pt) 2000-06-27
DE69838097D1 (de) 2007-08-30
EP0981537B1 (de) 2007-07-18
DE69838097T2 (de) 2008-04-10
ES2289782T3 (es) 2008-02-01
EP0981537A1 (de) 2000-03-01
US6248578B1 (en) 2001-06-19
KR20060014461A (ko) 2006-02-15
ATE367397T1 (de) 2007-08-15
KR20010012294A (ko) 2001-02-15
HK1025973A1 (en) 2000-12-01
AU7473198A (en) 1998-11-27
KR100585946B1 (ko) 2006-06-07
JP2002512519A (ja) 2002-04-23
PT981537E (pt) 2007-10-16
CN1255140A (zh) 2000-05-31
CA2289776C (en) 2008-10-21
CY1107730T1 (el) 2013-04-18
EP0981537A4 (de) 2002-09-18

Similar Documents

Publication Publication Date Title
Galinski et al. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3
Kato et al. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis
Schlender et al. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection
Buchholz et al. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
Radecke et al. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells
Van Der Werf et al. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.
CA2409432A1 (en) Modified morbillivirus v proteins
Garcia-Sastre et al. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus
Meyer et al. The nucleotide sequence of the fusion protein gene of the peste des petits ruminants virus: the long untranslated region in the 5′-end of the F-protein gene of morbilliviruses seems to be specific to each virus
Schneider et al. Rescue of measles virus using a replication-deficient vaccinia-T7 vector
DE69840361D1 (de) Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
Barrett et al. Nucleotide sequence of the entire protein coding region of canine distemper virus polymerase-associated (P) protein mRNA
Calain et al. Functional characterisation of the genomic and antigenomic promoters of Sendai virus
CY1105680T1 (el) Μολυσματικος κλωνος cdna βορειοαμερικανικου ιου χοιρειου αναπαραγωγικου και αναπνευστικου συνδρομου (prrs) και χρησεις αυτου
Skiadopoulos et al. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp 45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes
CA2236378A1 (en) Recombinant sendai virus
Johnston et al. A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism
AU3406595A (en) Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
EP1622928A2 (de) Insertion von furinprotease-schnittstellen in membranproteinen und anwendungen davon
Van Gennip et al. Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase
ID27206A (id) Generasi produk-produk perbanyakan gena dari protein-protein fusi simerik melalui pemutusan endoprotease ubikuitus
CY1107730T1 (el) Μολυσματικος κλωνος για ιο ανθρωπινης παραγριππης τυπου 3
Leyrer et al. Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue
CN106467910A (zh) L-dna/l-rna聚合酶及其应用
CA2333313A1 (en) Novel methods for rescue of rna viruses